首页|期刊导航|药物分析学报：英文版|Corrigendum to“The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection:A review”[J.Pharma.Anal.11(2021)265e271]

Corrigendum to“The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection:A review”[J.Pharma.Anal.11(2021)265e271]

Leonny Dwi Rizkita Indwiani Astuti

药物分析学报：英文版2022，Vol.12Issue(6)：P.937-937,1.

药物分析学报：英文版2022，Vol.12Issue(6)：P.937-937,1.DOI:10.1016/j.jpha.2022.11.001

Corrigendum to“The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection:A review”[J.Pharma.Anal.11(2021)265e271]

Leonny Dwi Rizkita ¹Indwiani Astuti¹

作者信息

1. Department of Pharmacology and Therapy,Faculty of Medicine,Public Health and Nursing,Universitas Gadjah Mada,Yogyakarta,55281,Indonesia
折叠

摘要

关键词

infection/Cor

分类

医药卫生

引用本文复制引用

Leonny Dwi Rizkita,Indwiani Astuti..Corrigendum to“The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection:A review”[J.Pharma.Anal.11(2021)265e271][J].药物分析学报：英文版,2022,12(6):P.937-937,1.

药物分析学报：英文版

OACSCDSCI

ISSN：2095-1779

访问量3

下载量0

段落导航